To investigate whether the reduction in cell viability in lung cancer cells after the combined WEE1/ATR inhibitor treatment was associated with increased S-phase DNA damage, we performed flow cytometry analysis of γH2AX induction. The gene discussed is ATR; the disease is lung carcinoma.